NCT00100620View on ClinicalTrials.gov

Efficacy and Safety of Zoledronic Acid in the Prevention and Treatment of Corticosteroid Induced Osteoporosis

PHASE3CompletedINTERVENTIONAL
Enrollment

802

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

April 30, 2007

Study Completion Date

April 30, 2007

Conditions
Osteoporosis
Interventions
DRUG

Zoledronic Acid

Trial Locations (6)

19610

Radiant Research, Wyomissing

21502

Osteoporosis & Clinical Trials, Cumberland

23249

McGuire VA Medical Center, Richmond

30501

United Osteoporosis Centers, Gainesville

43210

University of Ohio, Columbus

35294-3708

Center for Education and research on Therapeutics (CERTs) of Musculoskeletal Disorders, Birmingham

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY